These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

883 related items for PubMed ID: 19039558

  • 1. 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence.
    Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J, Shimosegawa E, Kanakura Y, Nakamura H, Hatazawa J.
    Ann Nucl Med; 2008 Nov; 22(9):795-802. PubMed ID: 19039558
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of 18F-FDG coincidence SPECT imaging and computed tomography in the initial staging and therapeutic evaluation of lymphomas].
    Qiao WL, Zhao JH, Wang C, He ZY, Wang TS, Xing Y.
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):536-9. PubMed ID: 18069637
    [Abstract] [Full Text] [Related]

  • 3. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.
    Acta Gastroenterol Belg; 2007 Jul; 70(4):331-8. PubMed ID: 18330088
    [Abstract] [Full Text] [Related]

  • 4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 5. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.
    Lai CH, Huang KG, See LC, Yen TC, Tsai CS, Chang TC, Chou HH, Ng KK, Hsueh S, Hong JH.
    Cancer; 2004 Feb 01; 100(3):544-52. PubMed ID: 14745871
    [Abstract] [Full Text] [Related]

  • 6. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.
    Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, Podoloff D.
    J Nucl Med; 2004 Jan 01; 45(1):17-21. PubMed ID: 14734662
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas.
    Kumar R, Xiu Y, Potenta S, Mavi A, Zhuang H, Yu JQ, Dhurairaj T, Dadparvar S, Alavi A.
    J Nucl Med; 2004 Nov 01; 45(11):1796-803. PubMed ID: 15534046
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT.
    Herrmann K, Queiroz M, Huellner MW, de Galiza Barbosa F, Buck A, Schaefer N, Stolzman P, Veit-Haibach P.
    BMC Cancer; 2015 Dec 23; 15():1002. PubMed ID: 26699124
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
    Mayerhoefer ME, Karanikas G, Kletter K, Prosch H, Kiesewetter B, Skrabs C, Porpaczy E, Weber M, Pinker-Domenig K, Berzaczy D, Hoffmann M, Sillaber C, Jaeger U, Müllauer L, Simonitsch-Klupp I, Dolak W, Gaiger A, Ubl P, Lukas J, Raderer M.
    Clin Cancer Res; 2014 Jun 01; 20(11):2984-93. PubMed ID: 24696320
    [Abstract] [Full Text] [Related]

  • 10. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
    Liu Y.
    Nucl Med Commun; 2017 Apr 01; 38(4):319-324. PubMed ID: 28225435
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
    Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L.
    Eur J Radiol; 2017 Apr 01; 89():14-19. PubMed ID: 28267530
    [Abstract] [Full Text] [Related]

  • 12. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH, Cho SK, Kim WS, Kim SJ, Chan Ahn Y, Choe YS, Lee KH, Kim BT, Choi JY.
    J Nucl Med; 2013 Jul 01; 54(7):1039-44. PubMed ID: 23658217
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S, Thephamongkhol K, Ubolnuch K, Pooliam J, Phongsawat N, Chiewvit P.
    J Med Assoc Thai; 2014 Jan 01; 97(1):85-94. PubMed ID: 24701734
    [Abstract] [Full Text] [Related]

  • 14. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P, Kuhn-Lansoy C, Edet-Sanson A, Hapdey S, Modzelewski R, Hitzel A, d'Anjou J, Basuyau JP.
    Thyroid; 2010 Jan 01; 20(1):15-23. PubMed ID: 20017617
    [Abstract] [Full Text] [Related]

  • 15. 18F-fluorodeoxyglucose-positron emission tomography in evaluation of primary cutaneous lymphoma.
    Kumar R, Xiu Y, Zhuang HM, Alavi A.
    Br J Dermatol; 2006 Aug 01; 155(2):357-63. PubMed ID: 16882175
    [Abstract] [Full Text] [Related]

  • 16. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Aug 01; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

  • 17. Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma.
    Mikosch P, Gallowitsch HJ, Zinke-Cerwenka W, Heinisch M, Pipam W, Eibl M, Kresnik E, Unterweger O, Linkesch W, Lind P.
    Acta Med Austriaca; 2003 Aug 01; 30(2):41-7. PubMed ID: 12752087
    [Abstract] [Full Text] [Related]

  • 18. Whole-body MRI for initial staging of paediatric lymphoma: prospective comparison to an FDG-PET/CT-based reference standard.
    Littooij AS, Kwee TC, Barber I, Granata C, Vermoolen MA, Enríquez G, Zsíros J, Soh SY, de Keizer B, Beek FJ, Hobbelink MG, Bierings MB, Stoker J, Nievelstein RA.
    Eur Radiol; 2014 May 01; 24(5):1153-65. PubMed ID: 24563179
    [Abstract] [Full Text] [Related]

  • 19. Clinical impact of whole body FDG-PET on the staging and therapeutic decision making for malignant lymphoma.
    Sasaki M, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Nakamura K, Masuda K.
    Ann Nucl Med; 2002 Jul 01; 16(5):337-45. PubMed ID: 12230093
    [Abstract] [Full Text] [Related]

  • 20. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 01; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.